DAXOR (DXR) Insider Filing: Jefferies Discloses Shares and Options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
John Jefferies, Chief Medical Officer of DAXOR CORP (DXR), filed an Initial Statement of Beneficial Ownership reporting 15,272 shares of DAXOR common stock owned directly. The filing lists multiple stock options exercisable for a total of ≈18,181 underlying shares across various grant dates and strike prices, with several tranches vesting by 12/01/2025 and one option presently exercisable in full.
Positive
- None.
Negative
- None.
Insider Trade Summary
24 transactions reported
Mixed
24 txns
Insider
Jefferies John
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Daxor Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 885 shares (Direct);
Daxor Common Stock — 15,272 shares (Direct)
Footnotes (1)
- This option is presently exercisable in full. The stock options will vest in three equal installments on December 1, 2023, December 1, 2024 and December 1, 2025.
FAQ
Who filed the Form 3 for DAXOR CORP (DXR)?
John Jefferies, identified as Chief Medical Officer, filed the Form 3.
What stock options are reported on the Form 3 for DXR?
The filing lists multiple stock options exercisable for common stock, including 885, 14,660, and several smaller tranches totaling about 18,181 underlying shares with strike prices from $9.09 to $13.96.
Are any options presently exercisable according to the filing?
Yes. The filing states that one option is presently exercisable in full.
When do the vesting tranches for the large option grant occur?
A large option grant vests in three equal installments on 12/01/2023, 12/01/2024, and 12/01/2025.